Alnylam Pharmaceuticals, Inc. (ALNY)
165.04
+8.39
(+5.36%)
USD |
NASDAQ |
Nov 13, 16:00
165.00
-0.04
(-0.02%)
After-Hours: 19:59
Alnylam Pharmaceuticals Price : 165.04 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 159.17 | 168.35 | 158.82 | 165.04 | 3.590M |
| Nov 12, 2026 | 160.16 | 162.77 | 156.59 | 156.65 | 3.516M |
| Nov 11, 2026 | 152.22 | 159.92 | 151.85 | 159.85 | 3.361M |
| Nov 10, 2026 | 155.02 | 158.82 | 149.18 | 151.64 | 2.456M |
| Nov 09, 2026 | 156.13 | 158.70 | 152.17 | 156.61 | 3.303M |
| Nov 06, 2026 | 155.22 | 159.45 | 154.30 | 155.94 | 2.830M |
| Nov 05, 2026 | 167.12 | 168.50 | 156.37 | 156.66 | 3.315M |
| Nov 04, 2026 | 166.73 | 170.49 | 160.29 | 161.08 | 3.638M |
| Nov 03, 2026 | 158.94 | 161.58 | 156.72 | 159.89 | 3.791M |
| Nov 02, 2026 | 163.10 | 163.90 | 156.00 | 158.00 | 4.764M |
| Oct 30, 2026 | 172.70 | 180.61 | 163.30 | 165.00 | 7.057M |
| Oct 29, 2026 | 185.59 | 202.37 | 172.31 | 174.00 | 11.80M |
| Oct 28, 2026 | 222.72 | 232.88 | 220.00 | 232.40 | 1.944M |
| Oct 27, 2026 | 225.00 | 228.49 | 222.82 | 226.79 | 1.603M |
| Oct 26, 2026 | 226.24 | 232.48 | 224.10 | 227.66 | 1.437M |
| Oct 23, 2026 | 227.28 | 229.39 | 222.00 | 224.03 | 1.056M |
| Oct 22, 2026 | 224.92 | 229.82 | 223.76 | 227.28 | 2.212M |
| Oct 21, 2026 | 227.86 | 230.84 | 224.88 | 225.10 | 1.181M |
| Oct 20, 2026 | 237.73 | 238.96 | 229.54 | 230.71 | 1.505M |
| Oct 19, 2026 | 232.64 | 236.54 | 231.26 | 233.29 | 1.344M |
| Oct 16, 2026 | 235.18 | 237.98 | 231.29 | 231.83 | 1.405M |
| Oct 15, 2026 | 230.00 | 234.30 | 228.12 | 234.03 | 1.257M |
| Oct 14, 2026 | 224.49 | 229.56 | 222.25 | 224.47 | 1.106M |
| Oct 13, 2026 | 228.93 | 229.52 | 221.56 | 223.82 | 1.119M |
| Oct 12, 2026 | 233.13 | 233.60 | 226.35 | 227.02 | 916918.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 29.06 |
| Vertex Pharmaceuticals, Inc. | 538.60 |
| Pfizer Inc. | 28.89 |
| Regeneron Pharmaceuticals, Inc. | 955.47 |
| BridgeBio Pharma, Inc. | 78.30 |
Price Related Metrics
| PE Ratio | 8.336 |
| PS Ratio | 4.533 |
| PEG Ratio | 0.0035 |
| Price to Book Value | 6.131 |
| Price to Free Cash Flow | 30.22 |
| Earnings Yield | 12.00% |
| Market Cap | 22.09B |
| PEGY Ratio | 0.0035 |
| Operating PE Ratio | 23.25 |
| Normalized PE Ratio | 8.640 |